Related Experiment Video
Updated: Mar 28, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Architecture of human mTOR complex 1
Christopher H S Aylett1, Evelyn Sauer2, Stefan Imseng2
1Institute of Molecular Biology and Biophysics, ETH Zürich, Zürich, Switzerland.
Abstract:
Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of mammalian TOR (mTOR) signaling is implicated in pathologies that include diabetes, cancer, and neurodegeneration. We resolved the architecture of human mTORC1 (mTOR with subunits Raptor and mLST8) bound to FK506 binding protein (FKBP)-rapamycin, by combining cryo-electron microscopy at 5.9 angstrom resolution with crystallographic studies of Chaetomium thermophilum Raptor at 4.3 angstrom resolution. The structure explains how FKBP-rapamycin and architectural elements of mTORC1 limit access to the recessed active site. Consistent with a role in substrate recognition and delivery, the conserved amino-terminal domain of Raptor is juxtaposed to the kinase active site.
Insights
Researchers revealed the structure of the human mTORC1 complex bound to FKBP-rapamycin. This structure clarifies how the complex
Area of Science:
- Molecular biology
- Cellular signaling
- Structural biology
Background:
- Target of rapamycin (TOR) is a key regulator of cell growth, existing in two complexes: TORC1 and TORC2.
- Dysregulated mammalian TOR (mTOR) signaling is linked to diseases like cancer, diabetes, and neurodegeneration.
Purpose of the Study:
- To determine the high-resolution architecture of the human mTORC1 complex bound to FKBP-rapamycin.
- To elucidate the structural mechanisms underlying mTORC1 regulation and substrate interaction.
Main Methods:
- Cryo-electron microscopy (cryo-EM) at 5.9 angstrom resolution.
- Crystallographic studies of Chaetomium thermophilum Raptor at 4.3 angstrom resolution.
Main Results:
- The study resolved the architecture of human mTORC1, including its subunits Raptor and mLST8, in complex with FKBP-rapamycin.
- The determined structure explains how FKBP-rapamycin and mTORC1's architecture restrict access to the active site.
- The conserved amino-terminal domain of Raptor is positioned near the kinase active site, suggesting a role in substrate recognition.
Conclusions:
- The resolved structure provides critical insights into the regulation of mTORC1 activity.
- Understanding mTORC1 architecture is crucial for developing therapeutic strategies targeting diseases associated with its dysregulation.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Assembly of Complex Microtubule Structures
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

